The Role of Phosphorus in Diet Induced Thermogenesis (DIT) of Both Lean and Obese Subjects
NCT ID: NCT02482142
Last Updated: 2020-10-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
64 participants
INTERVENTIONAL
2016-07-30
2019-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Investigating the impact of phosphorus ingestion on DIT of lean and obese subjects consuming high carbohydrate meal.
Investigating the impact of phosphorus ingestion on DIT of lean and obese subjects consuming high protein-low phosphorus meal.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Phosphorus Supplementation on Body Weight
NCT02329990
Effect of Food Acceptability on Appetite Hormones' Response in Normal Weight vs. Obese Male Subjects
NCT03779321
Nutritional Support in Patients With Nutritional Risk. How we Can Improved the Prognosis and Quality of Life
NCT05299541
Bread in Overweight/Obesity Treatment
NCT01223989
The Effect of Food Hedonics on Appetite Hormones Levels
NCT02615613
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A crossover design study will be used in which each subject will undertake 2 or 3 sessions in a random order over 2 or 3 different days which are separated by a minimum of one week. The difference between the sessions is the ingestion of placebo ( 4 tablets) or phosphorus (4 tablets, each contain 125mgof phosphorus) tablets with the appropriate meal.
Specific Aim 1: The impact of phosphorus ingestion on DIT of lean and obese subjects consuming high carbohydrate meal (Table 1: Meal 1).
This will be divided into two experiments:
Experiment 1.1: The impact of phosphorus ingestion on DIT of lean subjects consuming high carbohydrate meal (16 subjects).
In this experiment, overnight fasted lean subjects (\> 8 hours) will be requested to attend the testing room at around 8:00 am. Anthropometric measurements (weight, height, waist circumference) will be taken, rest for 30 min, measure resting energy expenditure (REE) for 30 min, ingest meal with the appropriate supplement and measure postprandial energy expenditure (PEE) for 4 hours (see figure 3). In this experiment, subject will undertake 3 sessions in a random order over 3 different days which are separated by a minimum of one week.
Session 1: Ingestion of phosphorus tablets (4 tablets) alone. No meal. Needed to determine the impact of phosphorus alone on DIT Session 2: Ingestion of phosphorus tablets (4 tablets) with the high carbohydrate meal (table1: Meal 1).
Session 3: Ingestion of placebo tablets (4 tablets) with the high carbohydrate meal (table 1: Meal 1).
Experiment 1.2: The impact of phosphorus ingestion on DIT of lean subjects consuming high carbohydrate meal (16 subjects).
In this experiment, overnight fasted obese subjects (\> 8 hours) will be requested to attend the testing room at around 8:00 am. Anthropometric measurements (weight, height, waist circumference) will be taken, rest for 30 min, measure resting REE for 30 min, ingest meal with the appropriate supplement and measure PEE for 4 hours (see figure 3). In this experiment, subject will undertake 3 sessions in a random order over 3 different days which are separated by a minimum of one week.
Session 1: Ingestion of phosphorus tablets (4 tables) alone. No meal. Needed to determine the impact of phosphorus alone on DIT Session 2: Ingestion of phosphorus tablets (4 tables) with the high carbohydrate meal (Table 1:Meal 1).
Session 3: Ingestion of placebo tablets (4 tables) with the high carbohydrate meal (Table 1:Meal 1).
Specific Aim 2: The impact of phosphorus ingestion on DIT of lean and obese subjects consuming high protein-low phosphorus meal (table 1: Meal 2).
This will be divided into two experiments:
Experiment 2.1: The impact of phosphorus ingestion on DIT of lean and obese subjects consuming high protein-low phosphorus meal (16 subjects).
In this experiment, overnight fasted lean subjects (\> 8 hours) will be requested to attend the testing room at around 8:00 am. Anthropometric measurements (weight, height, waist circumference) will be taken, rest for 30 min, measure REE for 30 min, ingest meal with the appropriate supplement and measure PEE for 4 hours (see figure 3). In this experiment, subject will undertake 2 sessions in a random order over 2 different days which are separated by a minimum of one week.
Session 1: Ingestion of phosphorus tablets (4 tablets) with the high protein meal (table1: Meal 2).
Session 2: Ingestion of placebo tablets (4 tablets) with the high protein meal (table 1: Meal 2).
Experiment 2.2: The impact of phosphorus ingestion on DIT of lean and obese subjects consuming high protein-low phosphorus meal (16 subjects).
In this experiment, overnight fasted obese subjects (\> 8 hours) will be requested to attend the testing room at around 8:00 am. Anthropometric measurements (weight, height, waist circumference) will be taken, rest for 30 min, measure REE for 30 min, ingest meal with the appropriate supplement and measure PEE for 4 hours (see figure 3). Urine sample over the experimental period will be collected. In this experiment, subject will undertake 2 sessions in a random order over 2 different days which are separated by a minimum of one week.
Session 1: Ingestion of phosphorus tablets (4 tablets) with the high protein meal (table1: Meal 2).
Session 2: Ingestion of placebo tablets (4 tablets) with the high protein meal (table 1: Meal 2).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
phosphorus alone
Effect of phosphorus (500mg) ingestion alone. No meal. Needed to determine the impact of phosphorus alone on DIT
Effect of phosphorus
Ingestion of 500mg of phosphorus ( 4 tablets, each of 125 mg of phosphorus)
high CHO meal alone
Ingestion of placebo tablets with the high carbohydrate meal
Effect of phosphorus
Ingestion of 500mg of phosphorus ( 4 tablets, each of 125 mg of phosphorus)
High CHO meal plus phosphorus
Effect of phosphorus (500mg) tablets ingestion of DIT of the high carbohydrate meal
Effect of phosphorus
Ingestion of 500mg of phosphorus ( 4 tablets, each of 125 mg of phosphorus)
High protein meal plus phosphorus
Effect of phosphorus (500mg) tablets ingestion of DIT of the high protein meal
Effect of phosphorus
Ingestion of 500mg of phosphorus ( 4 tablets, each of 125 mg of phosphorus)
High protein meal alone
Ingestion of placebo tablets with the high protein meal
Effect of phosphorus
Ingestion of 500mg of phosphorus ( 4 tablets, each of 125 mg of phosphorus)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Effect of phosphorus
Ingestion of 500mg of phosphorus ( 4 tablets, each of 125 mg of phosphorus)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* obese (BMI above 30) subjects
Exclusion Criteria
* Subjects on regular use of medication that affects body weight
* weight loss of 3% or more in the preceding 3 months
* Subjects with kidney disease
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American University of Beirut Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Omar A Obeid, PhD
Role: PRINCIPAL_INVESTIGATOR
American University of Beirut Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
American University of Beirut
Beirut, , Lebanon
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NUT.OO.22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.